Investment Committee Summary
| Rating | HOLD |
| Internal 5-tier | HOLD |
| Classification · conviction | mature cash generator · medium |
| Evidence | 8/8 load-bearing inputs sourced |
| Triangulated fair value | $190 (+10% vs spot · triangulated FV) |
| 12-mo scenario PWEV | $176 (+2% vs spot · 12m PWEV) |
| Next catalyst | 2026-10-05 — Ex-dividend $0.33/sh |
| Primary thesis-break | Consolidated combined ratio (life + health underwriting margin proxy) > deterioration such that the underwriting margin falls below ~24% (midpoint of the base 25.9% and soft-market 22.5% op-margin paths) (2 consecutive prints) |
Decision detail — rating tables & Research OS strip
Rating: HOLD
Internal 5-tier: HOLD · mature cash generator · analyst conviction: medium
| Metric | Value |
|---|---|
| Current Price | $173 |
| Triangulated Fair Value | $190 (+10% vs spot · triangulated FV) |
| 12-mo Scenario PWEV | $176 (+2% vs spot · 12m PWEV) |
| Forward P/E | 10.1x |
| Market Cap | $13B |
| 52-Week Range | $116–$186 (high/low reconstructed from the stock's own adjusted-close history — the vendor's recorded range was stale) |
EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).
Methodology: Valuation triangulated across four weighted anchors — an intrinsic DCF, a scenario-weighted PWEV, a Monte Carlo median (Student-t + regime switching) and a peer P/E re-rate. Anchors that share a market multiple are not independent evidence and are weighted as one view. Figures reconciled to Alpha Vantage 2026-08-24. Each chart below sits with the part of the thesis it evidences.
General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.
Decision Support — Research OS jump to detail ↓
| Research conviction | Exp. return (1y) | Rules stance | Preferred options | Next catalyst |
|---|---|---|---|---|
| 59.7/100 (57th pct) | +2% 1yr expected | Hold | Covered Call | 41d — Ex-dividend $0.33/sh |
Full breakdown — conviction components, position sizing, probability-return distribution, decision rules, factor & portfolio interaction, options intelligence and the catalyst timeline — in the Decision Support sections below. Model output for research; not individualised advice.
📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.
Recommendation: HOLD
Balanced: triangulated fair value $190 (+10% vs spot); the outcome hinges on P/E Multiple. The debate is P/E Multiple — fundamentally a multiple/regime call.
Investment Thesis
At $173 (25 August 2026) and roughly 10x forward earnings, Globe Life is priced close to the life-insurer peer median — the market believes in a normalised combined ratio and steady float income, with little scope left for re-rating. The engine reaches a similar place from a different direction. The blended anchor is $190, +10% against spot, so the shares are fairly valued against intrinsic value, while the twelve-month base-case target of $172 and the probability-weighted value of $176 sit slightly the other side of the quote. That split is the point: the distribution is two-sided rather than skewed. Mid-cycle earnings power reconciles with the simulated median and the peer-multiple anchor corroborates it, but roughly a fifth of the tree sits on a structural underwriting, reserve and catastrophe reset that drags the mean down. The single most damaging risk is adverse reserve remeasurement: a discrete mortality or morbidity assumption change would compress the underwriting margin and the multiple at the same time.
Narrative drafted 2026-08-16 by claude-opus-5 under supervision; reviewed by Marinus 2026-08-16.
The dashboard below is the whole argument on one page: spot ($173) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The highest-probability bear leg is the structural underwriting, reserve and catastrophe reset, carrying roughly a fifth of the weight. The mechanism is specific to a life insurer: reserve adequacy rests on long-dated mortality and morbidity assumptions, and a single adverse remeasurement forces both an earnings charge and a lower multiple, because the market begins to question the remaining reserve base rather than just this year's result. On that path the segment margin compresses well below today's 26%, earnings fall materially, and the rating de-rates toward a distressed multiple, taking the target beneath the 52-week low. Because underwriting and float income are the only earnings pillar, there is no offsetting segment to absorb the hit and no diversification argument to make. A strong return on equity offers a cushion, but the reset compounds a margin cut with a multiple cut inside the same reporting period.
Key Debate
P/E Multiple explains 67% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.
What the Market Is Pricing In
At the current price, the market pays 11.0× consensus forward EPS, and a peer median 9.9×.
Variant perception: the house view is below-consensus, and the thesis is primarily margin-driven.
| Metric | Consensus | House | Importance |
|---|---|---|---|
| Revenue | 6.4 | 6.4 | High |
| EPS | 15.7 | 17.2 | Medium |
| Target price | 193.9 | 171.8 | Medium |
Scenario Analysis
The scenario tree spans a structural 'Structural — Underwriting / Reserve / Catastrophe Reset' downside ($76.10) to a 'Bull — Re-Rate' bull case ($312); the probability-weighted blend (PWEV $176) is +2% versus spot.
| Scenario | Probability | Target | Return vs spot |
|---|---|---|---|
| Structural — Underwriting / Reserve / Catastrophe Reset | 20% | $76.10 | -56% |
| Soft Market / Investment Loss | 17% | $127 | -27% |
| Base — Mid-Cycle Combined Ratio | 35% | $184 | +7% |
| Growth — Hard Market / Pricing + Float Income | 20% | $248 | +43% |
| Bull — Re-Rate | 8% | $312 | +80% |
| Probability-Weighted (PWEV) | — | $176 | +2% |
Share-count charge: none applied. The probability-weighted value above is the gross per-share figure — no annual dilution is deducted — free cash flow net of SBC is $1.25B. SBC is therefore disclosed, not charged: read the per-share figures as before dilution.
Scenario rationale — the driver path behind every target:
- Structural — Underwriting / Reserve / Catastrophe Reset (20%, $76.10). Structural impairment — underwriting / reserve / catastrophe reset: earnings AND the multiple compress together. Target sits below the 52-week low by construction.
- Soft Market / Investment Loss (17%, $127). Cyclical downturn — premium growth + underwriting margin + investment income + reserves weakens for 1–2 years before normalising.
- Base — Mid-Cycle Combined Ratio (35%, $184). Mid-cycle — normalised premium growth + underwriting margin + investment income + reserves; disciplined capital allocation; steady returns.
- Growth — Hard Market / Pricing + Float Income (20%, $248). Upside — hard market + pricing lifts earnings above mid-cycle; the multiple expands modestly.
- Bull — Re-Rate (8%, $312). Upside tail — sustained tight conditions or a structural re-rate on hard market + pricing.
Valuation Triangulation
Four weighted anchors — an intrinsic dcf, a scenario-weighted pwev, a monte carlo median (student-t + regime switching) and a peer p/e re-rate — read them with their basis in mind. The Monte Carlo, the DCF terminal and any peer re-rate key off a market multiple, so they are not fully independent; only discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat four numbers as four independent votes.
| Method | Basis | Fair Value | vs Spot | Weight in this name's blend |
|---|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $155 | -11% | 18% (declared 15%) |
| Peer P/E re-rate | multiple | $171 | -1% | 12% (declared 10%) |
| Peer EV/Revenue re-rate | multiple | $66.61 | -62% | 0% — cross-check only |
| Scenario PWEV | multiple | $176 | +2% | 29% (declared 25%) |
| Justified P/B (ROE-based) | book value × ROE | $221 | +28% | 41% (declared 35%) |
| Triangulated (weighted) | — | $190 | +10% | 100% |
The house blend DECLARES five anchor weights — DCF 35%, scenario PWEV 25%, Monte Carlo 15%, sum-of-parts 15%, peer re-rate 10%. For this name sum-of-parts is not computed, so 15% of the declared weight is redistributed across the anchors that exist — which is why the weights above differ from the declared ones. The fair value is unaffected by this disclosure; the blend has always worked this way.
Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.
Book Value, ROE & Capital Returns
For a bank or insurer the cash-flow DCF is the wrong intrinsic anchor — capital is the product. Value is set by return on equity vs cost of equity against book value: the Gordon-justified multiple is P/B = (ROE − g) / (COE − g).
| Metric | Value |
|---|---|
| Book value / share | $78.12 |
| Return on equity (ROE) | 20.5% |
| Cost of equity (assumed) | 9.5% |
| Current P/B | 2.22x |
| Justified P/B (ROE-based) | 2.83x |
| Justified value / share | $221 (+28%) |
ROE of 20.5% comfortably clears the ~10% cost of equity — which is why a premium justified P/B of 2.83x (vs 2.22x current) is warranted. The justified value sits +28% vs spot; that gap, plus the credit / underwriting cycle in the scenarios, is the debate. The Monte Carlo and scenario PWEV carry the earnings (P/E) view; this block carries the book-value view.
Monte Carlo — the outcome distribution
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $155 and 39% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (67% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.
Peer benchmarking — relative value
Against the peer cohort, re-rating to the peer-median forward multiple (P/E 9.9x) implies $171. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so market sentiment does not set the fair value.
Across all anchors the spread is 91% of the median — wide (genuine disagreement — the blend carries low valuation confidence).
Peer Quality & Weighting
| Peer | Fwd P/E | Growth | Op margin | Quality | Weight cap |
|---|---|---|---|---|---|
| AFL | 14.5× | 5% | 30% | segment | 50% |
| MET | 9.3× | 5% | 10% | direct | 100% |
| PRU | 10.5× | 5% | 5% | direct | 100% |
| PFG | 9.4× | 5% | 15% | direct | 100% |
Quality-weighted forward P/E: 10.4× (simple median 9.9×). Direct peers count 100%, segment 50%, broad 25%.
Historical-range cross-check: 52-week range $116–$186, centre $147 (-15% vs spot); spot sits at the 82nd percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.
Risk / Reward & Margin of Safety
| Metric | Value |
|---|---|
| Upside to triangulated FV | $190 (+10% vs spot · triangulated FV) |
| Downside to bear case (Structural — Underwriting / Reserve / Catastrophe Reset) | $76.10 (-56% vs spot · bear scenario) |
| Reward/risk ratio | 0.2× |
| Margin of safety (FV vs spot) | +9% |
| P(price > spot) — Monte Carlo | 39% |
Reward/risk compares triangulated upside against the probability-weighted bear target, not the extreme tail. Bull case (Bull — Re-Rate): $312.
Company Overview & Business Model
Globe Life Inc — FINANCIAL SERVICES · INSURANCE - LIFE. Globe Life is a financial services holding company that operates through its wholly owned subsidiaries providing life insurance, annuity, and supplemental health insurance products. The company is based in McKinney, Texas.
How it makes money.
| Segment | Rev mix | Growth | Op margin | Key driver |
|---|---|---|---|---|
| Insurance (Underwriting + Float) | 100% | +5% | 26% | premium growth + underwriting margin + investment income + reserves |
Edge. Narrow moat — Globe Life's edge is a captive/exclusive agency distribution model selling small-face life and supplemental health to middle-income households, giving persistency and float, but it is a commoditized product with no pricing monopoly, so the moat is narrow; a ~10.4x multiple is appropriate for a mid-cycle combined ratio, and any reserve/underwriting reset or agency-force disruption should push the multiple below the life-insurer median rather than support re-rating.
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Op margin | EBIT | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|---|
| Insurance (Underwriting + Float) | $6.1B | 100% | 5% | 26% | $1.6B | 10.0x | 1% | ESTIMATE |
| EBIT = segment revenue × operating margin (segment EBITDA not shown — per-segment D&A is not separately disclosed). |
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | premium growth + underwriting margin + investment income + reserves |
| net_debt_or_cash_b | -2.52 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.01 |
| div_yield | 0.0065 |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | underwriting / reserve / catastrophe reset |
| upside | hard market + pricing |
Balance Sheet & Liquidity
| Metric | Value |
|---|---|
| Net debt | $-15.4B — net cash |
| Net debt / EBITDA | -9.18x |
| Interest coverage (EBIT / interest) | 10.4x |
| Current ratio | 9.66x |
| Cash & ST investments | $18.0B |
Balance-sheet data as of 2025-12-31 (Alpha Vantage).
Capital Allocation
| Metric | Value |
|---|---|
| Free cash flow | $1.3B |
| Buybacks / dividends | $0.9B / $0.1B |
| Total shareholder yield | 7.3% |
| Payout as % of FCF | 77.1% |
| Reinvestment (capex / OCF) | 10.2% |
| Allocation stance | returns-heavy |
Free-Cash-Flow Quality
| Metric | Value |
|---|---|
| FCF margin | 20.6% |
| FCF conversion (FCF / net income) | 108.0% |
| FCF yield | 9.5% |
| Capex intensity (capex / revenue) | 2.3% |
| FCF − SBC (diagnostic) | $1.2B |
| Capex split (maint / growth) | 85% / 15% — Insurers are capital-light on PP&E; 'capex' is minimal (systems/facilities), and growth investment is really agent recruiting and float deployment rather than physical capex. |
Accounting quality: SBC 1% of revenue; cash conversion (OCF/NI) 120% — cash-backed.
Competitive Moat
Moat sources:
- Captive/exclusive agency distribution (American Income, Liberty National) with recurring persistency
- Float from long-duration life/supplemental policies invested for spread income
- Underwriting/actuarial data on a narrow middle-income niche
- Offset: commoditized product, agent-recruiting dependence, and prior short-seller scrutiny on agency practices
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2026Q2): management +0.34 vs analyst floor +0.00 → delta +0.34 (n=37 mgmt / 24 Q&A; 36th pctile across the S&P book, z -0.4).
Flag: TYPICAL — management-vs-analyst tone within the normal cross-sectional range.
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2026Q2 | +0.34 | +0.00 | +0.34 |
| 2026Q1 | +0.28 | +0.00 | +0.28 |
| 2025Q4 | +0.27 | +0.03 | +0.24 |
| 2025Q3 | +0.31 | +0.05 | +0.26 |
News (last 365d, 1250 articles): avg ticker sentiment +0.09 (bullish 18% / bearish 11%)
Consensus & Market Expectations
| Reference | Value |
|---|---|
| Street target (mean) | $194 (+12% vs spot · street) |
| House target | $172 (-11.4% vs street) |
| Sell-side coverage | 11 analysts (SB 4 / B 4 / H 3 / S 0 / SS 0; net score 0.55) |
| Consensus FY EPS | $15.71; house above (+9.4%) |
| Consensus FY revenue | $6.4B; house in-line (-0.0%) |
_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.
Catalyst Calendar
- 2026-10-21 (~58d) — Quarterly earnings — est. EPS $4.83 (AV EARNINGS_CALENDAR)
- 2027-02-10 (~170d) — Capital return / buyback authorization update (authored)
Forecast Track Record
- EPS surprise: beat 50% of the last 8 quarters; average surprise +1.4%.
- Prior-forecast backtest (12 snapshots, 2026-06-27→2026-08-20): directional hit-rate 100%; mean predicted -4.7% vs realised -4.0%. Disconfirming track record is reported, not suppressed.
Catalyst Timeline
6 catalysts in the next 90 days (of 15 tracked). Importance 1–3; confidence 0–1.
| When | Catalyst | Type | Importance | Confidence |
|---|---|---|---|---|
| 2026-09-16 (in 22d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2026-09-18 (in 24d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2026-10-05 (in 41d) | Ex-dividend $0.33/sh | dividend | ● | 0.9 |
| 2026-10-14 (in 50d) | September CPI | macro | ●● | 0.8 |
| 2026-10-21 (in 57d) | Quarterly earnings | earnings | ●●● | 0.95 |
| 2026-10-28 (in 64d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2026-12-09 (in 106d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2026-12-18 (in 115d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2027-01-27 (in 155d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2027-02-10 (in 169d) | Capital return / buyback authorization update | authored | ● | 0.7 |
| 2027-03-17 (in 204d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2027-03-19 (in 206d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2027-04-28 (in 246d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2027-06-09 (in 288d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
_Sources: extended.catalysts, data/catalysts/
Regulatory & Legal Risk
| Issue | Probability | Valuation sensitivity | Horizon |
|---|---|---|---|
| State insurance-department market-conduct and agency-practice scrutiny | medium (~40%) | medium - reputational/agency-model risk; ~10% of FV | 12-24m |
| Statutory capital / RBC and reserve-basis changes | low (~30%) | medium - affects payout capacity; ~10% of FV | 12-24m |
Probabilities and sensitivities are analyst estimates, not market-implied.
Scenario Macro & Key Risks
| Scenario | Macro assumption | Key risk |
|---|---|---|
| Structural — Underwriting / Reserve / Catastrophe Reset | Adverse mortality/morbidity or reserve inadequacy forces a combined-ratio reset while agency-practice scrutiny pressures the model. | Earnings and multiple compress together below the life-insurer median. |
| Soft Market / Investment Loss | Falling rates compress float spread income and a credit drawdown hits the investment portfolio. | Spread income falls just as underwriting normalises, hitting both earnings legs. |
| Base — Mid-Cycle Combined Ratio | Normalised combined ratio and steady float income at prevailing rates sustain low-single-digit book-value growth. | Agent-count stagnation quietly caps future premium growth. |
| Growth — Hard Market / Pricing + Float Income | Firm pricing plus higher reinvestment yields lift both underwriting margin and float income. | Higher rates that help float income can coincide with weaker middle-income policy demand. |
| Bull — Re-Rate | Sustained agent growth and clean underwriting earn a re-rate toward the higher end of the peer range. | Any recurrence of agency-practice or reserve concerns reverses the re-rate quickly. |
Decision Rules (Machine-Checked)
Stance: Hold — 0 bullish / 0 bearish / 0 caution rules triggered of 6 evaluable (0 lacked data).
| Rule | Condition | Observed | Triggered |
|---|---|---|---|
| R1-valuation-stretch | expected return vs fair value < -12 (upside_pct) |
-0.77 | no |
| R2-valuation-opportunity | expected return vs fair value > 15 (upside_pct) |
-0.77 | no |
| R3-street-revisions | street net rating stance < -0.25 (extended.consensus.street_score) |
0.55 | no |
| R4-earnings-quality | cash conversion of earnings < 80 (extended.accounting_quality.cash_conversion_pct) |
120.2 | no |
| R5-technical-breakdown | price vs 200-day SMA < 0.85 (technicals.sma_200) |
1.14 | no |
| R6-vol-regime-shift | IV/RV vol-risk premium > 1.4 (options_overlay.iv_rv) |
0.85 | no |
Machine-checked rules over disclosed inputs. The authored falsification triggers elsewhere in this report are analyst judgment and are NOT evaluated here. The stance is a portfolio-management signal and does not modify the published research rating.
Reasons the Thesis Could Fail (Falsifiable)
Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:
- Consolidated combined ratio (life + health underwriting margin proxy) > deterioration such that the underwriting margin falls below ~24% (midpoint of the base 25.9% and soft-market 22.5% op-margin paths) (2 consecutive prints). A sustained margin below the base/soft midpoint signals the cyclical-downturn path is materialising rather than mid-cycle normalisation, moving weight from the base toward the soft-market and structural scenarios.
- Net policy obligation / reserve remeasurement charge > any material adverse remeasurement or reserve strengthening booked in the period (single event). Adverse reserve development is the mechanism of the structural-impairment scenario; a discrete strengthening charge is direct evidence the reset leg is live, not a soft-market blip.
- Net investment income yield on the fixed-maturity portfolio < new-money yield falling below the level assumed to sustain the base op-margin (float income turning into a drag rather than a support) (2 consecutive prints). Float income is a load-bearing input to the op-margin path; a persistent decline in the reinvestment yield pulls the earnings profile toward the soft-market case.
- Diluted book value per share (ex-AOCI) trend < sequential erosion below the reconciliation book value of $78.12/share driven by operating losses rather than capital returns (2 consecutive prints). Operating-driven book erosion (as distinct from buybacks) confirms capital is being consumed by underwriting/reserve losses, the pathway from the base into the structural scenario.
- Return on equity (trailing four quarters) < ROE falling below the ~9.5% cost of equity in the reconciliation, versus the ~20.5% recorded (2 consecutive prints). ROE dropping toward or below cost of equity removes the justification for a mid-cycle multiple and is the trigger for the re-rate premium in the growth/bull paths to unwind.
Fact / Inference / Speculation
- FACT: Spot $173; 52-week range $116–$186; engine rating HOLD; house target $172 (-1%). (source: Alpha Vantage 2026-08-24, 25 August 2026)
- INFERENCE: Triangulated FV $190 (+10% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits above the multiple-discipline core.
- SPECULATION: At current prices the embedded bet is that the market keeps paying the current multiple through the capex cycle — a regime call the engine cannot verify from fundamentals alone.
Conviction Score
Research Conviction measures the strength and quality of the research setup — input coverage, financial quality, valuation support, process agreement. It is NOT the probability that the recommendation succeeds; the forecast track record section is the evidence on that.
59.7/100 (confidence band 49.1–70.3), 57th percentile of 858 covered names (as of 2026-08-24). Weighted composite under config ros-1.19.0 — every component and its inputs below.
| Component | Score (0–100) | Weight | Inputs |
|---|---|---|---|
| business quality | 79 | 15% | extended.fcf_quality.fcf_margin_pct, extended.balance_sheet.net_debt_to_ebitda, extended.accounting_quality.cash_conversion_pct |
| financial strength | 83 | 10% | extended.balance_sheet.net_debt_to_ebitda, extended.balance_sheet.interest_coverage |
| valuation | 49 | 15% | upside_pct |
| growth | 52 | 10% | reconciliation.ttm_revenue_billions, reconciliation.fy_guide_revenue_billions |
| earnings visibility | 50 | 10% | extended.forecast_accuracy.eps_surprise.beat_rate_pct |
| moat | 55 | 10% | enrichment.moat.rating |
| technical trend (heuristic — no validation record; weight change reserved for AM-060) | 47 | 10% | technicals.rsi, technicals.sma_50, technicals.sma_200 |
| macro tailwinds | — | 10% | industry_context.house |
| risk profile | 58 | 10% | monte_carlo.prob_above_current, monte_carlo.p10, monte_carlo.p90, monte_carlo.median |
Missing inputs (macro tailwinds) are excluded and the remaining weights renormalised; the confidence band widens accordingly.
Score history: 63.0 → 63.0 → 63.2 → 62.8 → 62.8 → 60.0 → 59.7 → 59.7.
Probability-Weighted Return Profile
Horizon: 1 year — at this horizon CAGR equals total return by definition. Expected values are the probability-weighted sums over the full scenario set below.
| Scenario | Probability | Target | Total return | Contribution |
|---|---|---|---|---|
| Structural — Underwriting / Reserve / Catastrophe Reset | 20% | $76.10 | -56.0% | -11.2pp |
| Soft Market / Investment Loss | 17% | $127 | -26.9% | -4.6pp |
| Base — Mid-Cycle Combined Ratio | 35% | $184 | +6.6% | +2.3pp |
| Growth — Hard Market / Pricing + Float Income | 20% | $248 | +43.2% | +8.6pp |
| Bull — Re-Rate | 8% | $312 | +80.1% | +6.4pp |
| Aggregate | Value |
|---|---|
| Expected return (gross, 1y) | +1.6% |
| Expected return net of SBC dilution | +1.6% |
| Outcome dispersion (σ, from MC p10–p90) | 35.5% |
| Expected Sharpe (rf 4%) | -0.07 |
| Downside expectation (prob-weighted loss branches) | -15.8% |
The gross expected return is the probability-weighted scenario return (it reconciles to the gross PWEV); the diluted figure applies the SBC share-count charge and matches the published PWEV-based target.
Expected Alpha
Expected return minus the return this name is REQUIRED to deliver for its risk (1-year horizon). Constants are pre-registered (preregistered-static (amendment #2, 2026-07-29); not fitted to MCH outcomes).
| Component | Value |
|---|---|
| Expected return (gross, 1y) | 1.6% |
| Risk-free rate | 4.01% (1y proxy (3m/2y midpoint; AV lacks a 1y tenor), as of 2026-08-13) |
| Beta (shrunk, 1y vs SPY) | 0.56 (as of 2026-08-24) |
| Equity risk premium | 4.5% |
| Required return | 6.5% |
| Expected alpha | -4.9% |
| Alpha per unit risk (EA/σ) | -0.14 |
A negative expected alpha does not change the rating — it says the expected return does not clear the risk-adjusted hurdle at today's price. Rating mechanics are unchanged by this section.
Probability Cross-Checks
Not authoritative. The scenario probabilities in this report are AUTHORED — a judgement about how the world might go, not a measurement. Nothing below modifies them, the target, the rating or any position size. These checks ask only whether anything outside our own model agrees with us; where it does not, that is information for the reader, not a correction we have quietly applied.
| Cross-check | Ours | Comparator | Reading |
|---|---|---|---|
| Scenario spread vs options market | 40.6% (1σ) | 17.6% implied | broadly consistent with the market's implied uncertainty |
| Mass above spot: scenarios vs our own MC | 63.0% | 38.8% | the scenario weights and the MC parameters disagree about our OWN view — this is a model-coherence issue, not a market disagreement |
| Realised scenario frequency | 23 dated anchors | — | 23 dated anchors available; realised-vs-prior comparison is now meaningful. |
Authored set: 5 scenarios, probabilities summing to 1.0, mean target $175.84.
Flagged for review: internal coherence (authored mass vs Monte Carlo). A flag marks a disagreement worth understanding — it does not imply either side is wrong.
Factor Exposures
Cross-sectional percentiles over 858 covered names (style scores sector-demeaned; thematic = return-beta to the theme's proxy ETF). 50 = estate median.
| Style | Percentile | Theme | Percentile | |
|---|---|---|---|---|
| Growth | 46 | AI | 28 | |
| Value | 94 | Cloud | 32 | |
| Quality | 50 | Semis | 34 | |
| Momentum | 72 | Consumer | 32 | |
| Low-Vol | 63 | Rates | 34 | |
| USD | 73 | |||
| Energy | 37 |
Market interaction: correlation vs SPY +0.20, vs QQQ +0.12 (trailing ~1y daily returns).
Options Intelligence
Preferred structure: Covered Call. The selector reads the equity view (direction) and the volatility surface — nothing here re-prices the chain.
- range-bound with fair premium — harvest income against a holding
- Direction neutral from the overlay conviction/rating (read-only input).
- IV/RV at the 54th percentile of the cross-section → mid vol bucket. This is the measure that selects the structure above: it ranks how rich this name's implied vol is against its own realised vol, relative to other names.
- Reported alongside and not used to select: this name's own ATM IV sits at the 21st percentile of its own month-end history (decile 3). The two measures disagree here — vol is high for this name by its own history while its options are not unusually rich against its realised vol. Where they diverge, the cross-sectional measure is the one acting.
- IV term structure is in contango (longer-dated richer, slope +2.9pp) — favour longer-dated ownership (LEAPS) or calendars that are long the cheaper front.
IV term structure (contango, slope +2.9pp): 25-DTE 22% · 88-DTE 25% · 179-DTE 25%
| Priced structure | Value |
|---|---|
| Legs | Short 185 C |
| Expiry | 2026-09-18 |
| Income yield | 0.0% |
Economics copied verbatim from the options overlay (priced from the listed chain (EOD marks)); the selector does not re-price.
Alternatives: Cash-Secured Put. IV rank shown via the name's own monthly IV history (advisory); structure selected on the cross-sectional IV/RV percentile. Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.
Position Sizing Framework
| Parameter | Value |
|---|---|
| Initial position | 0.50% NAV |
| Maximum position | 0.83% NAV |
| Risk budget | 1.40% NAV |
| Annualized outcome σ (MC) | 35.5% |
| Indicative holding period | 3–12 months |
| Liquidity | high, ~$107M ADV (adv usd 21 (split-adjusted 21d average, AM-046)), ~0.1 days to exit |
| Rebalancing trigger | position drifts ±25% from target weight, or the decision-rules stance changes |
Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.
Options Overlay
A defined-risk way to express the HOLD equity view. Chain as of 2026-08-24 — end-of-day marks — indicative, not executable quotes.
Market signals — ATM IV 22.0% (moderate regime) · expected move ±4.6% (2026-09-18) · put/call OI 0.10 · ATM Δ 0.45 / Θ -0.08 / ν 0.18 · next earnings 2026-10-21. Direction: NEUTRAL (implied return -2.7% to triangulated fair value $168.47).
Covered Call (if held) (Income / neutral) — Short 185 C · 2026-09-18 · premium $0.01 · yield 0.0% · priced from the listed chain (EOD marks)
Converts a near-fair holding into income by agreeing to sell at a higher strike — worth weighing when upside looks limited near fair value and being called away is acceptable. Illustrative — no outcome is implied or guaranteed.
Put Spread (income) (Income / would-own) — Short 160 P / Long 145 P · 2026-10-16 · net $0.75 · net entry $159.25 · yield 0.5% · RoR 5.0% · max loss $14.25 · priced from the listed chain (EOD marks)
Gets paid to wait for a lower entry, with the tail capped: the sold put collects premium while the cheaper long wing below it caps the maximum loss at the spread width — a defined-risk alternative to a naked cash-secured put.
Protective Collar (if held) (Hedge) — Long 155 P / Short 190 C · 2027-02-19 · net $1.77 · floor -10.0% · cap +10.0% · priced from the listed chain (EOD marks)
For a holder who wants to stay invested but cap risk: the sold call funds most of the protective put, fencing the position into a band — a way to ride out a de-rating without selling.
Indicative options structures — a defined-risk expression of the equity view, model-and-market illustrated from the last-close chain. NOT personalised advice or an executable quote; premiums, IV and greeks move intraday. Options carry the risk of total loss of premium. Not a registered financial adviser.
Rating Bridge
Rating = HOLD because:
- Probability-weighted scenario value implies +2% vs spot
- Monte Carlo median implies -11% vs spot
- DCF fair value implies +28% vs spot
- Bear case (Structural — Underwriting / Reserve / Catastrophe Reset) downside is -56% vs spot
- Net: reward/risk of 0.2× is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.
Assumption Register
| Assumption | Value | Used in | Source |
|---|---|---|---|
| SBC dilution | 0.0%/yr | PWEV, MC, DCF (charged once) | estimate (from SBC/rev) |
| EPS basis | consensus forward EPS (broker-adjusted, non-GAAP) | all forward P/E & scenario multiples | definition |
Inputs, Sources & Confidence
Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)
| Input | Value | Type | Source | Confidence | Used in |
|---|---|---|---|---|---|
| Revenue TTM | $6.1B | reported fact | 10-K/10-Q via AV | High | Forecast base, EV/Rev |
| FY+1 guided revenue | $6.4B | company guidance | Company guidance | Medium | Forecast, SoP |
| Consensus FY EPS | $15.7103 | consensus estimate | Sell-side consensus via AV | Medium | Variant perception |
| Diluted shares | 0.076B | reported fact | 10-K via AV | High | Market cap, per-share |
| Net debt / cash | $-15.424B | reported fact | Balance sheet via AV | High | EV, DCF equity bridge |
Research Provenance
| Field | Value |
|---|---|
| Quantitative engine | mch_stock_engine v2.0 |
| Research OS config | ros-1.19.0 |
| Analysis as-of | 2026-08-25 (prices 2026-08-24) |
| Narrative authorship | claude-opus-5 · Claude Code, supervised, drafted 2026-08-16 |
| Human review | Marinus 2026-08-16 |
| Evidence | 8/8 load-bearing inputs sourced; 13/14 mandated claims cited |
| QA | scanned post-emit by the document-QA layer; the publication label (Draft / Research / Decision-level) is stamped on the published page, not authored here |
Load-Bearing Assumptions
DCF inputs (WACC, terminal multiple) are not applicable to this name's valuation adapter; triangulation leans 41% on DCF, 29% on PWEV, 18% on the Monte Carlo median, 12% on peer-implied value.
Appendix & audit trail — source log, data provenance, disclosures
Source Log
| Source | Type | Date | Used for | Reference |
|---|---|---|---|---|
| Alpha Vantage — GLOBAL_QUOTE / OVERVIEW | market data | 2026-08-24 | Price, market cap, EV, forward P/E | Alpha Vantage 2026-08-24 |
| MCH engine — trailing 252 adjusted closes | derived | 2026-08-24 | 52-week range (vendor's recorded range was stale and was replaced) | trailing 252 sessions of own close history; config value was stale |
| Company income statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-08-24 | Revenue, gross/operating margin, EBIT, interest expense | INCOME_STATEMENT / latest annual |
| Company balance sheet (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-08-24 | Cash, debt, net debt, leases, equity, coverage | BALANCE_SHEET / latest annual |
| Company cash-flow statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-08-24 | Operating cash flow, capex, FCF, buybacks, dividends, SBC | CASH_FLOW / latest annual |
| Company earnings releases via Alpha Vantage | reported fact | 2026-08-24 | Reported EPS, surprise history | EARNINGS / quarterly |
| Sell-side consensus via Alpha Vantage | consensus estimate | 2026-08-24 | Forward revenue/EPS consensus, analyst count | EARNINGS_ESTIMATES |
| Earnings calendar via Alpha Vantage | market data | 2026-08-24 | Next earnings date, catalyst timing | EARNINGS_CALENDAR |
| Company guidance | company guidance | 2026-08-24 | FY guided revenue / non-GAAP EPS basis | company guidance / earnings call |
| MCH segment model (from filings & disclosures) | house estimate | 2026-08-24 | Segment revenue, margins, multiples, AI decomposition | company_context (authored, tagged) |
| MCH qualitative analysis | inference | 2026-08-24 | Moat, regulatory risk, scenario macro, catalysts | company_context enrichment (authored) |
| MCH investment thesis & falsification triggers | house estimate | 2026-08-24 | Thesis, anti-thesis, thesis-break signals | authored §5.3 |
Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.
Data Sources
- Prices, fundamentals, options chain, earnings — Alpha Vantage.
- Company filings (10-K / 10-Q) — SEC filings via EDGAR.
Disclosures & Limitations
This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.
- This report is produced by the MCH Advisory quantitative research engine — valuation, scenarios, Monte Carlo and the decision layer are generated systematically from the disclosed inputs and the archetype/industry driver sets, and reviewed rather than written name-by-name. Every figure reconciles to the appendix and every score exposes its inputs.
- No suitability assessment has been performed for any individual.
- Market data may be delayed or inaccurate; figures are as of the analysis date.
- Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
- Forecasts are uncertain; past performance is not indicative of future returns.
- The author or publisher may hold positions in securities mentioned.
- Users should verify information against primary sources (company filings) before acting.
- Investing involves risk of loss; there is no guarantee any target price is achieved.
- Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.